Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma

March 22, 2017 updated by: George Athwal, Lawson Health Research Institute

Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma: A Randomized Prospective Double-blinded Study.

Patients who present to our institution with a traumatic injury to their elbow who need operative management will be randomized to one of two groups; a treatment arm and a control arm. The treatment arm will receive a three-week postoperative course of indomethacin while the control group will not. We will follow both groups to assess whether or not indomethacin prophylaxis affects the rate of heterotopic ossification.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: George Athwal, MD
  • Phone Number: 66081 519-646-6100
  • Email: <gathwal@uwo.ca>

Study Contact Backup

Study Locations

    • Ontario
      • London, Ontario, Canada, N6A 4V2
        • Recruiting
        • HULC, St Joseph's Health Care
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 83 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Terrible Triad
  • Radial head fracture surgical treatment
  • Monteggia and Trans-olecranon Fracture Dislocations
  • Distal Biceps Tendon Injuries
  • Distal Humerus Fractures
  • Coronoid Fractures
  • Capitellar-Trochlear fractures
  • Olecranon Fractures

Exclusion Criteria:

  • Associated Traumatic Brain Injury
  • Burn Injuries associated with elbow trauma
  • History of Gastric Ulcers
  • Documented allergies to any Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Severe Asthma
  • Previous operative fixation to affected elbow
  • Participation in other research study
  • Inability to speak / understand English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: drug
The treatment arm will receive 21 days of Indomethacin and Pantoprazole (gastrointestinal protective agent). The patients will receive Indomethacin 25mg three times a day and Pantoprozole 40mg once a day.
Placebo Comparator: placebo
The placebo group will receive microcrystalline cellulose powder tablets to be taken as a control. The placebo will be dosed at the same intervals and duration as the treatment arm in this study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in post operative radiographic evaluation
Time Frame: 6 weeks and 3, 6 and 12 mfup
AS a standard care patients will be routinely assess at three, six , twelve and twenty four months post-operatively.
6 weeks and 3, 6 and 12 mfup

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in range of motion
Time Frame: 6 weeks and 3, 6 and 12 mfup
measuring range of motion with a goniometer will be performed at 6 weeks and 3, 6 and 12 mfup
6 weeks and 3, 6 and 12 mfup
Patient Rate Elbow Evaluation
Time Frame: 6 weeks and 3, 6 and 12 mfup
is a 20-item questionnaire designed to measure elbow pain and disability
6 weeks and 3, 6 and 12 mfup
The Mayo Elbow Performance score
Time Frame: 6 weeks and 3, 6 and 12 mfup
is an instrument used to test the limitations to use the elbow during ADL caused by the pathology
6 weeks and 3, 6 and 12 mfup
Disabilities of the Arm, Shoulder and Hand
Time Frame: 6 weeks and 3, 6 and 12 mfup
is a 30-item, self-report questionnaire designed to measure physical function and symptoms in people with any of several musculoskeletal disorders of the upper limb.
6 weeks and 3, 6 and 12 mfup

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Anticipated)

November 1, 2019

Study Completion (Anticipated)

November 1, 2019

Study Registration Dates

First Submitted

November 19, 2012

First Submitted That Met QC Criteria

December 5, 2012

First Posted (Estimate)

December 6, 2012

Study Record Updates

Last Update Posted (Actual)

March 23, 2017

Last Update Submitted That Met QC Criteria

March 22, 2017

Last Verified

March 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elbow Trauma Requiring Operative Management

Clinical Trials on Indomethacin and Pantoprazole

3
Subscribe